跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Abrin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Abrin
Approved
STANDARD
Abrin
The Searle Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
77dcedcc95271fbf
Company
The Searle Company Limited
Type
Standard
Approval Details
Approval Id
77dcedcc95271fbf
Drug Approval Philippines Name
Abrin
Product Name
Abrin
Registration Number
DR-XY49087
Brand Name
Abrin
Generic Name
Ivabradine (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
7.5 mg
Manufacturer
The Searle Company Limited
Importer
Getz Bros. Philippines, Inc.
Distributor
Getz Bros. Philippines, Inc.
Company Detail Path
/organization/the-searle-company-limited
Issuance Date
21 May 2024
Expiry Date
21 May 2029
Pharmacologic Category
Other Cardiac Preparation.
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
77dcedcc95271fbf
Type
Standard
Back to Philippines FDA Approvals